Rimrock Gold Corp. (RMRK) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 5.73 means the share price is 5.73 times one year of earnings per share.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerRimrock Gold Corp. (RMRK) trades at $0.0003. Rimrock Gold Corp. focuses on developing and marketing CBD products. The company operates in the specialty and generic drug manufacturing sector. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for RMRK: RMRK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Rimrock Gold Corp. (RMRK) Healthcare & Pipeline Overview
Rimrock Gold Corp., operating in the healthcare sector, specializes in the development and marketing of CBD oils, creams, and hemp extracts. Based in Las Vegas, the company targets the growing market for CBD products, facing competition from both established pharmaceutical companies and emerging cannabis-based businesses.
What Is the Investment Thesis for RMRK?
Rimrock Gold Corp. presents a speculative investment opportunity within the burgeoning CBD market. With a market capitalization of $0.00B and a P/E ratio of 5.73, the company's valuation reflects its early stage and potential for growth. Key value drivers include successful product development, effective marketing, and strategic partnerships. Growth catalysts include expanding distribution channels and capitalizing on increasing consumer demand for CBD products. However, potential risks include regulatory uncertainty, intense competition, and limited financial resources. The company's beta of -0.29 suggests a low correlation with the overall market, potentially offering diversification benefits. Investors should carefully assess the company's ability to execute its growth strategy and navigate the evolving regulatory environment.
Based on FMP financials and quantitative analysis
RMRK Key Highlights
Rimrock Gold Corp. operates in the high-growth CBD market, projected to reach $16 billion by 2026, driven by increasing consumer awareness and acceptance of CBD products.
- The company's focus on CBD oils, creams, and hemp extracts aligns with consumer demand for alternative wellness solutions.
- Rimrock Gold Corp. has a P/E ratio of 5.73, indicating potential value relative to earnings, but this should be viewed cautiously given the company's small market cap.
- The company's beta of -0.29 suggests a low correlation with the overall market, potentially offering diversification benefits.
- Rimrock Gold Corp. is based in Las Vegas, Nevada, a strategic location for accessing both domestic and international markets.
Who Are RMRK's Competitors?
RMRK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MEDS TRxADE HEALTH, Inc. | $3.68 | -9.36% | $9.65M | — |
| MSLE Satellos Bioscience Inc. Common Stock | $8.50 | -0.12% | $11.0M | 33 5-pillar |
| NEUP Neuphoria Therapeutics Inc. | $3.47 | -1.14% | $18.8M | — |
| AIXC AIxCrypto Holdings, Inc. | $1.01 | -39.16% | $20.4M | — |
| RNTX Rein Therapeutics, Inc. | $0.80 | -6.03% | $22.4M | — |
| KYNB Kyntra Bio, Inc. | $6.31 | -2.92% | $25.5M | — |
| YI 111, Inc. | $3.22 | -2.57% | $28.1M | 39 5-pillar |
| PETS PetMed Express, Inc. | $1.36 | -0.73% | $29.1M | 32 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RMRK's Key Strengths?
Focus on the growing CBD market.
- Established product line of CBD oils, creams, and hemp extracts.
- Strategic location in Las Vegas, Nevada.
What Are RMRK's Weaknesses?
Small market capitalization.
- Limited financial resources.
- Dependence on a single product category (CBD).
What Are the Key Risks for RMRK?
Negative return on equity (-49.1%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Regulatory uncertainty surrounding CBD products could negatively impact the company's operations.
- Intense competition from other CBD companies could erode market share.
- Negative publicity or product recalls could damage the company's reputation.
- Fluctuations in the price of hemp and other raw materials could impact profitability.
What Are RMRK's Competitive Advantages?
- Proprietary formulations of CBD products.
- Established distribution network.
- Brand recognition in the CBD market.
What Does RMRK Do?
Rimrock Gold Corp., established in 2007 and based in Las Vegas, Nevada, operates through its subsidiary to develop and market a range of CBD-based products, including oils, creams, and hemp extracts. The company aims to capitalize on the increasing consumer interest in CBD products for wellness and therapeutic purposes. Rimrock Gold Corp. focuses on formulating and distributing these products, targeting consumers seeking alternative health and wellness solutions. The company's product line is designed to cater to various consumer preferences and needs, with different formulations and delivery methods. Rimrock Gold Corp. competes with other companies in the CBD market, including both established pharmaceutical companies and smaller, specialized CBD product manufacturers. The company's success depends on its ability to develop effective products, build brand awareness, and navigate the evolving regulatory landscape for CBD products.
What Products and Services Does RMRK Offer?
- Develop and market CBD oils.
- Produce and sell CBD creams.
- Offer hemp extracts for various applications.
- Formulate CBD products for wellness purposes.
- Distribute CBD products through various channels.
- Target consumers seeking alternative health solutions.
How Does RMRK Make Money?
- Develops and manufactures CBD-based products.
- Markets and sells products directly to consumers and through distributors.
- Generates revenue through product sales.
What Industry Does RMRK Operate In?
Rimrock Gold Corp. operates within the rapidly expanding CBD market, which is experiencing significant growth due to increasing consumer awareness and acceptance of CBD products for wellness and therapeutic purposes. The market is characterized by intense competition, with numerous companies offering a wide range of CBD products. Regulatory uncertainty remains a significant challenge for the industry, as regulations vary by jurisdiction and are constantly evolving. Rimrock Gold Corp. competes with both established pharmaceutical companies and smaller, specialized CBD product manufacturers. The company's success depends on its ability to differentiate its products, build brand awareness, and navigate the regulatory landscape.
Who Are RMRK's Key Customers?
- Individuals seeking alternative health and wellness solutions.
- Consumers interested in CBD products for therapeutic purposes.
- Retailers and distributors of health and wellness products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Rimrock Gold Corp. operates in the Healthcare sector. It is headquartered in Las Vegas, US. The company is led by CEO Jordan Starkman. RMRK has traded publicly since 2009.
Key Financial Metrics
Return on equity for Rimrock Gold Corp. stands at -49.1%, a gauge of how efficiently it converts shareholder capital into profit. RMRK trades at a trailing price-to-earnings ratio of 5.73, below the Healthcare sector average of ~21.10x. Its earnings yield is 17.4%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Rimrock Gold Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
RMRK Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
RMRK Latest News
No recent news available for RMRK.
RMRK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RMRK.
Price Targets
Wall Street price target analysis for RMRK.
RMRK MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RMRK; grades run from A+ (80-100) to F (below 30).
Leadership: Jordan Starkman
CEO
Jordan Starkman serves as the CEO of Rimrock Gold Corp., managing a small team of two employees. His leadership is focused on guiding the company's strategy in the competitive CBD market.
Track Record: Due to limited information available, Jordan Starkman's specific achievements, strategic decisions, and company milestones under his leadership cannot be detailed. The company's performance and growth trajectory under his guidance require further assessment.
RMRK OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Rimrock Gold Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Potential for illiquidity and wide bid-ask spreads.
- Higher risk of fraud or manipulation.
- Lack of regulatory oversight and investor protection.
- Uncertainty regarding the company's financial viability.
- Verify the company's legal status and registration.
- Obtain and review any available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their experience.
- Determine the level of trading volume and liquidity.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Company has been in operation since 2007.
- Focus on the growing CBD market.
- Presence of a CEO (Jordan Starkman).
Common Questions About RMRK (Healthcare)
What does Rimrock Gold Corp. do?
Rimrock Gold Corp. is a healthcare company focused on the development and marketing of CBD oils, creams, and hemp extracts.
What do analysts say about RMRK stock?
As of 2026-03-17, there is no available analyst coverage or consensus on Rimrock Gold Corp. (RMRK) due to its small market capitalization and OTC listing.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on Rimrock Gold Corp. due to its OTC listing and small market capitalization.